甲状腺疾病和肌缩侧面硬化症
Tracy Peters1,2, Haomin Yang3,4, Zhangyu Zou5
1Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China, tracy.peters@gmail.com.
Neuroepidemiology
|November 21, 2025
概括
甲状腺疾病与发展肌缩性侧面硬化症 (ALS) 的风险中等增加有关. 这种关联是在英国大型生物库研究中观察到的,突出显示了对甲状腺疾病和ALS进行进一步研究的需要.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 流行病学 流行病学
背景情况:
- 甲状腺疾病越来越多地被认为是它在神经退行性疾病病理学中的潜在作用.
- 甲状腺功能障碍和肌缩性侧面硬化症 (ALS) 之间的特定关系仍然不完全理解.
研究的目的:
- 调查甲状腺疾病之间的联系,包括甲状腺功能低下症和甲状腺功能过高症,以及随后发展ALS的风险.
- 分析甲状腺状况对大型队列中ALS发病率的影响.
主要方法:
- 采用2006年至2010年期间注册的参与者的英国生物库数据,采用匹配的队列研究设计,随访延长至2022年.
- 考克斯的比例危险模型被用来计算ALS风险的危险比率 (HRs) 和95%置信区间 (CI).
主要成果:
- 该研究包括42684名甲状腺疾病患者,其中80%为女性.
- 甲状腺疾病与ALS发病风险增加存在中度关联 (HR: 1.44,95%CI: 1.02-2.02),在调整儿童身高后一致.
- 高甲状腺症可能与60岁或更年轻的个体 (HR: 21.22) 和女性 (HR: 3.02) 的ALS风险较高有关.
结论:
- 甲状腺疾病与发展肌缩性侧面硬化症的风险适度增加有关.
- 进一步的综合性研究是必要的,以阐明甲状腺疾病和ALS病因之间的复杂相互作用.
相关概念视频
01:26Cross-bridge Cycle
122.0K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
122.0K
01:20Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
03:03Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
03:03Amyloid Fibrils
6.3K
6.3K
01:15Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K